Florida Region


5810 Coral Ridge Drive, Suite 300 Coral Springs, Florida 33076

Percutaneous Repair of the Mitral Valve (Mitraclip)

Percutaneous Repair of the Mitral Valve (Mitraclip)

Physicians at Palm Beach Gardens Medical Center are at the forefront of cardiac care in the United States by offering the minimally invasive MitraClip device as an option for patients suffering from mitral regurgitation (MR).

MR is a debilitating, progressive and life-threatening disease in which a leaky mitral valve causes a backward flow of blood into the heart. The condition can raise the risk of irregular heartbeats, stroke and heart failure, which can be deadly. Mitral regurgitation is common, affecting more than 4 million Americans – nearly one in 10 people aged 75 and above.

Medications for the condition only assist with symptom management and do not stop the progression of the disease, so typically open heart mitral valve surgery is the standard of care treatment. Now that the MitraClip device has been approved for U.S. patients with severe symptomatic degenerative MR, the number of invasive mitral valve surgeries performed may be reduced.

MitraClip, made by Abbott Vascular, repairs the mitral valve without the need for an invasive surgical procedure. The device is delivered to the heart through the femoral vein, a blood vessel in the leg. Once implanted, it allows the heart to pump blood more efficiently, thereby relieving symptoms and improving patients’ quality of life. Patients undergoing MitraClip treatment typically experience shorter recovery times and reduced hospital stays of about three days.

Multiple trials, published reports and registries of patients treated with the MitraClip device consistently demonstrate a positive safety profile, reduction in mitral regurgitation, improvement in symptoms and reduction in hospitalizations for heart failure, even in some of the most ill and debilitated patients. So far, more than 11,000 patients in more than 30 countries have been treated with the MitraClip device.

Palm Beach Gardens Medical Center is participating in the COAPT clinical trial to determine whether the device can be used as a treatment for patients with heart failure and functional MR, a type of MR in which the damaged heart impairs the performance of a normal mitral valve.

To find out if you are a candidate for MitraClip, call: (561) 799-5417 and ask to speak to the patient navigator.

For more information, visit The Heart Institute at Palm Beach Gardens Medical Center.

Stay Connected

Join us on Facebook

Watch us on YouTube

Follow us on Twitter